PainReform Ltd. Files 6-K, Incorporates Press Release
Ticker: PRFX · Form: 6-K · Filed: Sep 10, 2024 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | Sep 10, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $1.58 Million |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, registration-statement, press-release
TL;DR
PainReform filed a 6-K, linking a press release to its S-8 and F-3 filings. Details TBD.
AI Summary
PainReform Ltd. filed a Form 6-K on September 10, 2024, to report information as a foreign private issuer. This filing incorporates by reference a press release (Exhibit 99.1) into its existing Registration Statements on Form S-8 and Form F-3. The press release details are not provided in this excerpt.
Why It Matters
This filing indicates PainReform is updating or referencing information within its existing SEC filings, which could be relevant for investors tracking the company's disclosures.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates a press release into existing registration statements, with no new material financial or operational information provided in this excerpt.
Key Players & Entities
- PainReform Ltd. (company) — Filer of the 6-K report
- 001-39481 (company) — SEC File Number for PainReform Ltd.
- 333-257968 (company) — Form S-8 Registration Statement number
- 333-265902 (company) — Form S-8 Registration Statement number
- 333-259318 (company) — Form F-3 Registration Statement number
- 333-254982 (company) — Form F-3 Registration Statement number
- 333-276485 (company) — Form F-3 Registration Statement number
- 333-277594 (company) — Form F-3 Registration Statement number
FAQ
What is the purpose of this Form 6-K filing by PainReform Ltd.?
The purpose is to report information as a foreign private issuer and to incorporate by reference a press release (Exhibit 99.1) into the Company's existing Registration Statements on Form S-8 and Form F-3.
When was this Form 6-K filed?
The filing was made on September 10, 2024.
Which SEC registration statements are being updated by this filing?
The filing incorporates information into Registration Statements on Form S-8 (No. 333-257968 and 333-265902) and Form F-3 (No. 333-259318, 333-254982, 333-276485, and 333-277594).
What is the principal executive office address for PainReform Ltd.?
The principal executive offices are located at 65 Yigal Alon St., Tel Aviv 6744316, Israel.
Does PainReform Ltd. file annual reports under Form 20-F or Form 40-F?
PainReform Ltd. files annual reports under Form 20-F, as indicated by the checkmark next to 'Form 20-F'.
Filing Stats: 251 words · 1 min read · ~1 pages · Grade level 9.7 · Accepted 2024-09-10 09:13:25
Key Financial Figures
- $1.58 Million — form Announces Exercise of Warrants for $1.58 Million Gross Proceeds". A copy of the press re
Filing Documents
- zk2422018.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 11KB
- 0001178913-24-003032.txt ( ) — 22KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 10, 2024 PAINREFORM LTD. By: /s/ Ehud Geller Ehud Geller Interim Chief Executive Officer